Bactobio

Bactobio is a London-based biotechnology company leveraging breakthrough technologies in synthetic biology, next-generation sequencing, and machine learning to cultivate 99% of previously uncultivable microorganisms. Bactobio has exclusive access to the largest biological resource in life, enabling them to discover new chemical and biological products through pharmaceuticals, agriculture, and bio-derived chemicals sectors. Their first objective is to help address the growing crisis of antimicrobial resistance.